Wen‐fang Cheng - Gynecology

Author Information

Dr. Wen-fang Cheng is affiliated with the Department of Obstetrics and Gynecology at the College of Medicine, National Taiwan University, located in Taipei, Taiwan. Dr. Cheng has a significant academic presence and has contributed extensively to the field of gynecology through both research and clinical practice.

Research Contributions

Dr. Wen-fang Cheng has made substantial contributions to the field of gynecology and oncology, particularly focusing on ovarian and endometrial cancers. Her research spans various areas including the prediction of long-term prognoses in ovarian clear cell carcinoma, the risk of secondary malignancies among endometrial cancer survivors, and the evaluation of modern adjuvant radiotherapy in endometrial cancer. She has also explored the discordancy between intraoperative frozen sections and final pathologies in ovarian tumors, as well as the impact of chemotherapeutic regimens on the survival of patients with recurrent advanced epithelial ovarian carcinoma.

Aliases

Dr. Wen-fang Cheng is also known by several aliases in academic and research circles, including W.-f. Cheng, Wen-fang Cheng, Wen Fang Cheng, W F Cheng, and W. F. Cheng.

Publication and Citation Metrics

Metric	Value
Citation Count	4433
H-Index	37
Paper Count	196

Publications:

Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study

DOI: 10.3390/cancers14071746

Year: 2022

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis

DOI: 10.1002/cam4.3861

Year: 2021

A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes

DOI: 10.3390/biomedicines9101384

Year: 2021

Stereotactic body radiation combined with oncolytic vaccinia virus induces potent anti-tumor effect by triggering tumor cell necroptosis and DAMPs.

DOI: 10.1016/j.canlet.2021.09.040

Year: 2021

Age-Specific Trend and Birth Cohort Effect on Different Histologic Types of Uterine Corpus Cancers

DOI: 10.21203/rs.3.rs-1019009/v1

Year: 2021

Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors

DOI: 10.3389/fonc.2021.694441

Year: 2021

Rare clinical manifestations of primary peritoneal serous carcinoma presenting as colorectal cancer: A report of two cases.

DOI: 10.1016/j.tjog.2021.01.018

Year: 2021

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction

DOI: 10.3389/fonc.2021.675972

Year: 2021

Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer

DOI: 10.3390/cancers13061386

Year: 2021

Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study

DOI: 10.3390/ijerph18126629

Year: 2021

Why is MRI Important in Gynecology?

What Role Does Nutrition Play in Preventing Gynecological Cancers?

What is Conization?

Can I Use a Health Savings Account (HSA) or Flexible Spending Account (FSA)?

What are the benefits of minimally invasive surgery in gynecology?

What are the Alternatives to Karyotype Analysis?

What About Acne During Pregnancy?

What is Personalized Medicine in Gynecology?

Why is advanced imaging important in gynecological surgery?

What should one discuss with their gynecologist?

Partnered Content Networks

Relevant Topics